Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-22

Clinical Trial Update: Study of AR-13324 in Patients With Elevated Intraocular Pressure [Phase 2]

View source ↗

Summary

Phase 2 trial results for AR-13324 in patients with elevated intraocular pressure have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AR-13324 (netarsudil)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2018-02-22